This statistic depicts the percentage of cumulative clinical trials started globally between 2000 and 2018, by cancer type. During these years, lung cancer-related clinical trials made up 3.1 percent of all clinical trials, followed closely by breast cancer with three percent of clinical trials started.
Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type*
* Trials looking at two or more indications are repeat counted for each indication.
** “Other indications” includes those indications not shown as well as tumor-agnostic
trials that do not specify any tumor type; if a trial lists both specified and unspecified tumor types, then
it would be counted under each of the specified tumor types.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
L.E.K. Consulting, & Personalized Medicine Coalition. (November 26, 2019). Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type* [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/1092728/cumulative-clinical-trial-starts-share-by-cancer-indication/
L.E.K. Consulting, und Personalized Medicine Coalition. "Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type*." Chart. November 26, 2019. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/1092728/cumulative-clinical-trial-starts-share-by-cancer-indication/
L.E.K. Consulting, Personalized Medicine Coalition. (2019). Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type*. Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/1092728/cumulative-clinical-trial-starts-share-by-cancer-indication/
L.E.K. Consulting, and Personalized Medicine Coalition. "Percentage of Cumulative Clinical Trials Started Worldwide between 2000 and 2018, by Cancer Type*." Statista, Statista Inc., 26 Nov 2019, https://www.statista.com/statistics/1092728/cumulative-clinical-trial-starts-share-by-cancer-indication/
L.E.K. Consulting & Personalized Medicine Coalition, Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type* Statista, https://www.statista.com/statistics/1092728/cumulative-clinical-trial-starts-share-by-cancer-indication/ (last visited August 25, 2024)
Percentage of cumulative clinical trials started worldwide between 2000 and 2018, by cancer type* [Graph], L.E.K. Consulting, & Personalized Medicine Coalition, November 26, 2019. [Online]. Available: https://www.statista.com/statistics/1092728/cumulative-clinical-trial-starts-share-by-cancer-indication/
